18th Biosimilars Congregation 2023 | Event in Mumbai | Townscript
18th Biosimilars Congregation 2023 | Event in Mumbai | Townscript

18th Biosimilars Congregation 2023

Dec 13 '23 | 09:30 AM (IST)

Event Information

                       18th Biosimilars Congregation 2023

                 13th December 2023, Hotel Kohinoor Continental, Mumbai, India 

Virtue Insight is delighted to invite you to attend the 18th Biosimilars Congregation 2023 conference, to be held on 13th December 2023, Hotel Kohinoor Continental, Mumbai, India . It brings together scientists, researchers and CROs from around the world. At 18th Biosimilars Congregation 2023 meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community.


ClinChoice, Clinion, MedClinica, MP Biomedicals, Biolinx India, Foxx Life Sciences 

Conference Sponsorship/Exhibit/Booth/Branding/Paid Speaking opportunities available. 


E-mail - kavitha@virtueinsight.co.in or Call - + 91 9361957193

  • Standard Price - INR 15,000 + GST (18%) per delegate


  • HANMANT BARKATE, Senior VP & Head - Global Medical Affairs, Glenmark
  • RAHUL GUPTA, Vice President, Regulatory Affairs, USV
  • SANJEEV GUPTA, VP & Head-Advanced Biotech (Biosimilar), Ipca Laboratories
  • PRATEEK GUPTA, SVP & Head, Technical Development & MSAT, Stelis Biopharma
  • UDAY HARLE, Asst. Vice President /Head Global Clinical Research, Biologics NCE Vaccines - Amneal Group
  • KUMAR GAURAV, Director Medical Affairs, Dr. Reddy’s Laboratories
  • SATISH KOLTE, Global Head of Projects and Engineering, Sun Pharma
  • SANTOSH TAUR, Director Medical Affairs - Vaccines & Digital, Pfizer
  • KETAKI SABNIS-PRASAD, Assistant Director & Head Development Quality Assurance Biotech, Lupin
  • AKSHAYA ODAK, Head - Regulatory (Biotech), Lupin
  • HARSHAD KOTHAWADE, Head of Regulatory Management & Trade Compliance, Merck Group
  • MILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai Associates
  • ROSHAN PAWAR, Head Medical Affairs, Alkem Laboratories
  • PANKAJ THAKUR, GM, Clinical Project Management - Drug Discovery, Biologics, Hetero Labs
  • SAKHARAM GARALE, Founder & CEO, RENOVARE Healthcare Solutions
  • KHOKAN DEBNATH, Sr GM / (Head) – Regulatory Affairs, Clinical Operations, PV & QA (India & Emerging Market), Wockhardt
  • SWEETY MATHEW, Regulatory Professional- Global Regulatory Affairs: CMC Rare Diseases, Novo Nordisk
  • APARNA PRABHUNE, Asst GM, Regulatory Affairs, Wockhardt
  • SAMIR KULKARNI, Head - DBT ICT Center, Institute Of Chemical Technology
  • PRASHANT BODHE, Director, CliniSearch
  • RAHUL BHAMBURE, Senior Scientist, National Chemical Laboratory
  • RANJIT BARSHIKAR, CEO, QBD International, United Nations Adviser
  • VISHWAS SOVANI, Founder Director, Pharmawisdom
  • MANGALA KOTNIS, Former Head Regional Medical Affairs (MSL/ FME function), Abbott
  • KAVYA KADAM, Consultant Global Clinical Trials
  • VARSHA NARAYANAN, Founder-Director, Dr Varsha’s Health Solutions (Medical Expert, National Health Authority (NHA))


  • Develop a Biosimilar – Outlining the pipeline
  • New Era of Biosimilars: Future Challenges & Opportunities, Interchangeability studies
  • Imperatives for R&D in biosimilars - Entering the next wave of growth
  • Global Perspectives: Impact of Biosimilars around the world – What have we learned so far?
  • Commitment to Quality - Excellence in manufacturing biosimilars
  • (CGMP) standards in quality control, supported by advanced technologies & scientific expertise
  • Overcoming Barriers to the Market Access of Biosimilars
  • Who can influence payers on Biosimilar decision making
  • What type of evidence will be needed for registering Biosimilars in the future?
  • Real-world Data from multiple sources to conduct Biosimilar comparison studies
  • Ensuring the balance between product development and patient safety
  • Technology: Unlocking the better ways
  • Regulatory - Product Development Considerations
  • What comes next for the industry?
  • Be part of a major networking opportunity


CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:

Biopharmaceuticals/Biotherapeutics, Follow on Biologics/Follow on Proteins, Biologics/Biotechnology/ Bio generics, Legal Affairs, Intellectual Property, Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Pharmacovigilance, Drug Safety & Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science, Portfolio Management, Research & Development, Business Development, Business Operations, Scientific Affairs, Commercial Affair

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.


Kohinoor Continental
J B Nagar, Andheri East, Mumbai Suburban, Mumbai, India
Virtue Insight cover image
Virtue Insight profile image
Virtue Insight
Joined on Feb 7, 2017
Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry.
Have a question?
Send your queries to the event organizer
Virtue Insight profile image
Have a question?
Send your queries to the event organizer
Virtue Insight profile image
Host Virtual Events with
Learn More TsLive Learn more